EAA方案治疗难治性及复发性急性白血病疗效观察  

Observation of Effects of EAA Regimen for Refractory and Relapsed Acute Leukemia

作　　者：李丹红[1] 代英波[1] 杜俊英[1] 

机构地区：[1]牡丹江医学院红旗医院血液科,牡丹江157011

出　　处：《世界科技研究与发展》2008年第4期485-486,共2页World Sci-Tech R&D

摘　　要：目的探讨难治性急性白血病(AL)的治疗方法。方法采用安吖啶(AMSA)、阿糖胞苷(Ara-c)、依托泊苷(Vp16)组成的EAA方案治疗38例难治性复发性AL并观察疗效。结果38例病人完全缓解15例,部分缓解10例,总有效率65%。结论EAA方案是治疗难治性复发性AL有效的方法。Objective To explore the therapy of refractory and relapsed AL. Method Treated and observed effects of 38 cases of refractory and relapsed AL by using EAA regimen integrated with AMSA,Ara-c and Vp16. Results Of 38 patients there were 15 cases of complete remission, 10 cases of partial remission, and the total effective rate was 65 %. Conclusion EAA regimen proved to be an effective therapy in treating refraetory and relapsed AL.

关 键 词：白血病 安吖啶 依托泊苷 阿糖胞苷 

分 类 号：R733.7[医药卫生—肿瘤]